Evidence map›Paper›PMID 37109407›Full record

ArticleLife (Basel, Switzerland)2023

WNT16 Regulation of the Articular Chondrocyte Phenotype in Mice.

Subburaman Mohan, Shelia Pourteymoor, Chandrasekhar Kesavan

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Subburaman MohanMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA 92357, USA.ORCID 0000-0003-0063-986X
Shelia PourteymoorMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA 92357, USA.
Chandrasekhar KesavanMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA 92357, USA.

Funding

Transgenic Approaches to Evaluate IGF-I Role in Peak BMDR01AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH &EDUC · PI MOHAN, SUBBURAMAN · 2003 to 2025
$4.7M
Transgenic Approaches to Evalute IGF-1 Role in Peak BMDR56AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2008 to 2008
$258k
BLRD Research Career Scientist Award ApplicationIK6BX005381 · VA · VA LOMA LINDA HEALTHCARE SYSTEM · PI SUBBURAMAN MOHAN · 2021 to 2026
–
BLRD VA I01 BX001396BLRD VA IK6 BX005381NIAMS NIH HHS R01 AR048139NIAMS NIH HHS R56 AR048139
6 · The paper itself

Abstract

The anabolic effects of WNT16 on osteoblasts are well established, however, little is known regarding the role of WNT16 in chondrocytes. In this study, we evaluated

Indexed as

cell culturechondrocyteschondrogenesismiceosteoarthritisWNT16

Identifiers

PMID37109407
PMCPMC10145094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.